𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sialic acid as a marker for differentiation between benign and malignant intracranial tumors

✍ Scribed by Egon Marth; Gerhard Flaschka; Sylvia Stiegler; Josef Richard Möse

Book ID
115826149
Publisher
Elsevier Science
Year
1988
Tongue
English
Weight
429 KB
Volume
176
Category
Article
ISSN
0009-8981

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum sialic acid is a biologic marker f
Serum sialic acid is a biologic marker for malignant disease
✍ Ujjaini Khanderia; James H. Keller; H. Barton Grossman 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB

Serial serum sialic acid (N-acetylneuraminic acid) was measured in 16 patients with advanced cancer of various histologic types. In the 15 evaluable patients serial changes in sialic acid correlated with the clinical course. Isolated sialic acid values were not predictive of clinical response. Seria

Multiparametric magnetic resonance imagi
Multiparametric magnetic resonance imaging for the differentiation between benign and malignant salivary gland tumors
✍ Sato Eida; Misa Sumi; Takashi Nakamura 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB

## Abstract ## Purpose: To evaluate the stepwise approach in differentiating between benign and malignant salivary gland tumors using time‐intensity curves (TICs) and apparent diffusion coefficients (ADCs). ## Materials and Methods: TICs and ADCs were analyzed on the tumor‐by‐tumor (overall) and

Significance of serum protein and lipid-
Significance of serum protein and lipid-bound sialic acid as a marker for genitourinary malignancies
✍ Kemal M. Erbil; Sabri E. Sen; Horst Zincke; James D. Jones 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 516 KB

A prospective study was done to evaluate the roles of serum N-acetylneuraminic acid (NANA) and the lipid-bound subfraction of sialic acid (LSA) concentrations in the detection and staging of cancer, and the follow-up of treatment in patients with genitourinary malignancies. Multiple determinations w

A novel 21-kDa protein as a serum marker
A novel 21-kDa protein as a serum marker for benign and malignant urogenital tumors: Preliminary communication
✍ C. Shalitin; R. Epelbaum; C. Valansi; R. Segal; T. Mekori; B. Lover; E. Robinson 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 736 KB

## Abstract A novel 21‐kDa protein (p21) was isolated from auto‐immune complexes, found in sera of 14 patients with malignant urogenital tumors and isolated on Protein A‐Sepharose. Isolated complexes were analyzed in 15% polyacrylamide‐SDS minigels. After staining with Coornassie blue R, the bands